Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 5/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | MAOA | P21397 | 5/20 | 0.46 |
| ▸ | MAOB | P27338 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aniline SCHEMBL7723094 | 1.00 | TSHR (0.79) | TSHRCYP3A4TDP1TAAR1HSD17B10 | |
| Aniline SCHEMBL30876135 | 0.89 | — | — | |
| SCHEMBL18517570 | 0.89 | TSHR (1.00) | TSHRCYP3A4TDP1TAAR1HSD17B10 | |
| Aniline SCHEMBL29395910 | 0.89 | — | — | |
| Aniline SCHEMBL11811648 | 0.89 | TSHR (1.00) | TSHRCYP3A4TDP1TAAR1HSD17B10 | |
| Aniline SCHEMBL16922171 | 0.89 | — | — | |
| Aniline SCHEMBL9755597 | 0.89 | TSHR (1.00) | TSHRCYP3A4TDP1TAAR1HSD17B10 | |
| Aniline SCHEMBL11803 | 0.89 | — | — | |
| SCHEMBL22096536 | 0.89 | TSHR (1.00) | TSHRCYP3A4TDP1TAAR1HSD17B10 | |
| Aniline SCHEMBL30471194 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106932568-B | A kind of preparation method based on interface transform electrochemical luminescence immunosensor | 济南大学 | 2019-04-23 | — | — | CN | claimed |
| CN-106932568-B | A kind of preparation method based on interface transform electrochemical luminescence immunosensor | 济南大学 | 2019-04-23 | — | — | CN | disclosed |
| CN-1547870-B | Light emitting apparatus and electronic device | SEIKO EPSON CORP | 2011-01-19 | — | — | CN | disclosed |
| US-20100317653-A1 | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS | ASTRAZENECA AB (SE) | 2010-12-16 | — | — | US | disclosed |
| US-7795283-B2 | Oxadiazole derivative as DGAT inhibitors | ASTRAZENECA AB (SE) | 2010-09-14 | — | — | US | disclosed |
| CN-100499075-C | Electroluminescence device, method of manufacturing electroluminescence device, and electronic apparatus | SEIKO EPSON CORP (JP) | 2009-06-10 | — | — | CN | disclosed |
| US-20080096874-A1 | Oxadiazole Derivative as Dgat Inhibitors | ASTRAZENECA AB (SE) | 2008-04-24 | — | — | US | disclosed |
| EP-1833806-A1 | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS | AstraZeneca AB (SE) | 2007-09-19 | — | — | EP | disclosed |
| CN-1941358-A | Circuit substrate, electro-optical device and electronic apparatus | SEIKO EPSON CORP (JP) | 2007-04-04 | — | — | CN | disclosed |
| CN-1897252-A | Electroluminescence device, method of manufacturing electroluminescence device, and electronic apparatus | SEIKO EPSON CORP (JP) | 2007-01-17 | — | — | CN | disclosed |
| CN-1873969-A | Circuit board, electro-optical device, and electronic apparatus | SEIKO EPSON CORP (JP) | 2006-12-06 | — | — | CN | disclosed |
| CN-1278786-C | Liquid material ejecting method and device, electro-optical device, and method for manufacturing substrate thereof | SEIKO EPSON CORP (JP) | 2006-10-11 | — | — | CN | disclosed |
| CN-1827234-A | Jetting method of liquid, jetting apparatus of liquid, production method of substrate for electro-optical apparatus and production method of electro-optical apparatus | SEIKO EPSON CORP (JP) | 2006-09-06 | — | — | CN | disclosed |
| CN-1268000-C | Circuit board, electro-optical device, and electronic apparatus | SEIKO EPSON CORP (JP) | 2006-08-02 | — | — | CN | disclosed |
| WO-2006064189-A1 | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS | ASTRAZENECA AB (SE) | 2006-06-22 | — | — | WO | disclosed |
| CN-1547870-A | Light emitting apparatus and electronic device | ������������ʽ���� | 2004-11-17 | — | — | CN | disclosed |
| CN-1472014-A | Liquid material ejecting method and device, electro-optical device, and method for manufacturing substrate thereof | ������������ʽ���� | 2004-02-04 | — | — | CN | disclosed |
| CN-1435804-A | Circuit board, electro-optical device, and electronic apparatus | SEIKO EPSON CORP (JP) | 2003-08-13 | — | — | CN | disclosed |
| CN-1009006-B | Thermosetting resin composition, and prepreg and laminated sheet material produced from the same | HITACHI LTD (JP) | 1990-08-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317653-A1 | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS | DGAT1, DGAT2, GPR119 | TSHR 1451/4885CYP3A4 551/4885TDP1 4089/4885 |
| US-20080096874-A1 | Oxadiazole Derivative as Dgat Inhibitors | DGAT1, DGAT2, GPR119 | TSHR 1169/4885CYP3A4 544/4885TDP1 3959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.